Arbutus Biopharma (ABUS) Receivables - Other (2010 - 2018)

Arbutus Biopharma has disclosed Receivables - Other across 9 years of filings, most recently posting $128000.0 for Q1 2018.

• Receivables - Other for Q1 2018 came in at $128000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2018 was $128000.0 (changed 0.0% YoY), and the FY2017 annual result was $128000.0, changed 0.0% from the prior year.
• Receivables - Other came in at $128000.0 for Q1 2018 at Arbutus Biopharma, roughly flat from $128000.0 in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $1.6 million in Q1 2015 to a low of $128000.0 in Q4 2015.
• The 5-year median for Receivables - Other is $128000.0 (2015), against an average of $370705.9.
• Across the five-year window, Receivables - Other jumped 249602.92% in 2014 and slumped 91.97% in 2016, its largest moves.
• Arbutus Biopharma's Receivables - Other stood at $538000.0 in 2014, then tumbled by 76.21% to $128000.0 in 2015, then changed by 0.0% to $128000.0 in 2016, then changed by 0.0% to $128000.0 in 2017, then changed by 0.0% to $128000.0 in 2018.
• The last three Receivables - Other figures came in at $128000.0 (Q1 2018), $128000.0 (Q4 2017), and $128000.0 (Q3 2017), per Business Quant data.